The Hidden Receptor Behind Ketamine’s Power
This discovery around ketamine's brain mechanism trigger holds promise for refining ketamine treatments for more effective treatments.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
This discovery around ketamine's brain mechanism trigger holds promise for refining ketamine treatments for more effective treatments.
Read More
Johns Hopkins Medicine recommends psychedelics research guidelines. And is leading efforts to refine key areas of psychedelic research.
Read More
The American Society of Anesthesiologists issued guidance around the proper ans safe use of ketamine treatments.
Read More
A recent study has uncovered promising findings regarding ketamine as a treatment for severe obsessive-compulsive disorder (OCD).
Read More
A growing body of research suggests that psychedelics can do more than just alter perception—they can deepen human connections.
Read More
(UVA) has received a $9.3 million grant from the NIH to study ketamine as a potential treatment for status epilepticus.
Read More
The FDA has expanded the approval of Johnson & Johnson's nasal spray, Spravato, for standalone use in treating major depressive disorder.
Read More
In this study, low-dose ketamine led to significant improvements in mood and cognition within just a few hours of treatment.
Read More
Starting January 1st, Wisconsin Medicaid will cover IV ketamine therapy for major depressive disorder, including cases with suicidality.
Read More
The death of “Friends” star Matthew Perry has put ketamine under the spotlight. This CNN ketamine flashdoc dives into this emerging therapy.
Read More